Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared on X:
”It was so exciting to talk to KTLA 5 Morning News about the new pill that is now an option for our patients with pancreas cancer. (Daraxonrasib)
Opens door for patients with other cancers as well that are RAS-driven.”
Pashtoon Kasi was recognized among OncoDaily’s The 100 Most Influential People in Colorectal Cancer in 2024, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
You can also read: FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer
